Skip to main content
ConductScienceScienceDex

Al-Hilal, Taslim A

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #11,652
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Pharmacology

NIH Funding · FY2023

Linked Award Amount
$899.8K
Full award amounts, FY2023
Award Records
5
Records listing this PI
Award-Linked Rank
#11,652
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Al-Hilal, Taslim A. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Al-Hilal, Taslim A as a PI. Multi-PI records show the full award amount for context.

  • 5SC1GM144171-02SC1Contact PI
    Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
    University of Texas El Paso
    $383.8K
    award amount
  • 7R01CA262788-03R01Contact PI
    Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity
    University of Utah · Pharmacology (NIH department code)
    $342.2K
    award amount
  • 7R21CA264627-03R21Contact PI
    The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer
    University of Utah · Pharmacology (NIH department code)
    $173.9K
    award amount
  • 5R01CA262788-02R01Contact PI
    Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity
    University of Texas El Paso
    $1
    award amount
  • 5R21CA264627-02R21Contact PI
    The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer
    University of Texas El Paso
    $1
    award amount

Award organizations

Organizations that administered FY2023 awards listing Al-Hilal, Taslim A as a PI.

University of Utah
UT
$516K
2 grants
University of Texas El Paso
TX
$383.8K
3 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2022
    First NIH Award
    University of Utah
  2. 2022
    $500K Cumulative Funding
  3. 2022
    R01 Grant Holder
  4. 2023
    $1M Cumulative Funding
  5. 2023
    Multi-Institutional Research
    Awards at 2 institutions

Explore further

Find collaborators for Al-Hilal, Taslim A

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →